Durlax Top Surface Limited (NSE:DURLAX)
43.60
-1.70 (-3.75%)
Feb 19, 2026, 3:29 PM IST
Durlax Top Surface Revenue
Durlax Top Surface had revenue of 681.88M INR in the half year ending September 30, 2025, with 76.63% growth. This brings the company's revenue in the last twelve months to 1.31B, up 17.68% year-over-year. In the fiscal year ending March 31, 2025, Durlax Top Surface had annual revenue of 1.23B with 35.13% growth.
Revenue (ttm)
1.31B
Revenue Growth
+17.68%
P/S Ratio
0.57
Revenue / Employee
17.07M
Employees
77
Market Cap
753.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.23B | 318.88M | 35.13% |
| Mar 31, 2024 | 907.64M | 240.26M | 36.00% |
| Mar 31, 2023 | 667.38M | 193.80M | 40.92% |
| Mar 31, 2022 | 473.58M | 278.12M | 142.29% |
| Mar 31, 2021 | 195.46M | -109.43M | -35.89% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuracy Shipping | 7.46B |
| Arabian Petroleum | 3.28B |
| Veekayem Fashion and Apparels | 2.97B |
| ROX Hi-Tech | 2.10B |
| Sonu Infratech | 2.08B |
| K2 Infragen | 1.86B |
| Accretion Pharmaceuticals | 826.43M |
| Aakaar Medical Technologies | 592.04M |